Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Non Operating Investment Income (2016 - 2021)

Tenax Therapeutics' Non Operating Investment Income history spans 4 years, with the latest figure at $10444.0 for Q4 2017.

  • On a quarterly basis, Non Operating Investment Income fell 84.7% to $10444.0 in Q4 2017 year-over-year; TTM through Dec 2017 was -$2526.0, a 97.72% increase, with the full-year FY2021 number at -$70.0, down 113.26% from a year prior.
  • Non Operating Investment Income hit $10444.0 in Q4 2017 for Tenax Therapeutics, up from -$3767.0 in the prior quarter.
  • Over the last five years, Non Operating Investment Income for TENX hit a ceiling of $156160.0 in Q4 2015 and a floor of -$140237.0 in Q1 2016.
  • Historically, Non Operating Investment Income has averaged $3200.3 across 4 years, with a median of -$3213.5 in 2017.
  • The widest YoY moves for Non Operating Investment Income: up 410.84% in 2016, down 214.85% in 2016.
  • Tracing TENX's Non Operating Investment Income over 4 years: stood at -$23254.0 in 2014, then surged by 771.54% to $156160.0 in 2015, then crashed by 56.29% to $68261.0 in 2016, then tumbled by 84.7% to $10444.0 in 2017.
  • Business Quant data shows Non Operating Investment Income for TENX at $10444.0 in Q4 2017, -$3767.0 in Q3 2017, and -$2660.0 in Q2 2017.